Ewing sarcoma, including classical Ewing sarcoma of the bone and primitive neuroectodermal tumors arising in bone or extraosseous primary sites, is a highly aggressive childhood neoplasm. We present two cases of Ewing sarcoma arising from the vagina in young girls. Previously reported cases in literature focused on their pathologic rather than radiographic features. We describe the spectrum of multimodality imaging appearances of Ewing sarcoma at this unusual primary site. Awareness of vaginal Ewing tumors may facilitate prompt diagnosis and lead to a different surgical approach than the more commonly encountered vaginal rhabdomyosarcoma.
Introduction

T
he World Health Organization currently uses the term Ewing sarcoma to include classical Ewing of the bone as well as extraosseous Ewing, Askin tumor of the thoracic wall, and primitive peripheral neuroectodermal tumors. [1] Because Ewing sarcoma has a common biology and treatment regardless of the primary site or degree of cellular differentiation, distinctions based on location and histologic variations are no longer utilized for classification or therapy. Virtually, all Ewing sarcomas share a common chromosomal translocation of the long arm of chromosome 11 and 22. The translocation of the EWSR1 gene on to chromosome 22p12 next to the FLI1 gene usually results in upregulation of insulin-like growth factor 1 which plays a role in cellular proliferation. [2] The common translocation and a strong membranous expression of CD99 unify the diagnosis of classical and extraosseous Ewing sarcoma, supporting the use of the new nomenclature.
clinical entity can facilitate early diagnosis and appropriate treatment, which may improve prognosis.
Case Reports
Case 1
A 12-year-old female began menarche with heavy bleeding and menorrhagia. Use of oral contraceptives resulted in a notable decrease in symptomatology. Subsequent acute onset of urinary retention prompted an Emergency Department (ED) visit 3 months later. Pelvic ultrasound was performed, demonstrating a large solid, heterogeneous mass, located posterior to the bladder, presumably vaginal [ Figure 1a ] which was further characterized by a contrast-enhanced magnetic resonance (MR) examination [ Figure 1b -f], obtained after placement of a Foley catheter. On MR imaging (MRI), the lesion was confirmed to arise from the vagina. The patient was transferred to our hospital for further management with a presumptive diagnosis of rhabdomyosarcoma. Biopsy was performed. Subsequent staging The tumor cells had diffuse membranous CD99 expression by immunohistochemistry, and the EWSR1 gene rearrangement was detected by fluorescent in situ hybridization (FISH), consistent with a diagnosis of Ewing sarcoma. Bone marrow aspiration and biopsy were negative for marrow metastases. Chemotherapy with vincristine, cyclophosphamide, and doxorubicin alternating with ifosfamide and etoposide was instituted. [6] After completion of chemotherapy, the patient developed progressive metastatic lung disease and a left parietal metastatic lesion, being currently managed with palliative treatment.
Case 2
A 15-year-old female with progressive abdominal fullness and discomfort, profuse menstrual bleeding, and malodorous vaginal discharge for 3 months presented to the ED with a lobulated, vascular mass protruding from the vaginal introitus. The patient started chemotherapy with vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide and etoposide. Following 12 weeks of neoadjuvant chemotherapy, a complete surgical resection of the posterior vaginal mass with preservation of the vagina was performed. Since the resected tumor was >90% necrotic without extension to the surgical margins, no adjuvant radiation therapy was given. The patient had no evidence of recurrent disease 12 months after therapy completion.
Discussion
Extraskeletal Ewing tumors are usually rapidly growing deep soft tissue masses, often presenting with pain and/or a large mass (average 5-10 cm at presentation), similar to our cases. Time to diagnosis is one of the longest as compared to other pediatric tumors; however, it is not associated with worsened prognosis. [7] The most frequent sites of origin in decreasing order of the prevalence include the paravertebral region, lower extremity, chest wall, retroperitoneum, pelvis, and hip. [7] The lung is the most common site of metastatic spread. [8] Pathologically, these tumors are often well demarcated with early involvement of adjacent soft tissues occurring in many cases. Histology shows sheets of small round blue cells sometimes intermixed in a fibrous stroma. Necrosis and hemorrhage are not uncommon.
The imaging appearance of extraosseous Ewing sarcoma is usually that of a hypervascular soft tissue mass with areas of necrosis or hemorrhage, which may abut adjacent bone but does not involve the marrow space. Calcifications are present in up to 25% of cases. [3] The proposed diagnostic imaging criteria for extraskeletal Ewing sarcoma rely on the absence of adjacent bony invasion on MRI with no abnormal uptake on delayed imaging technetium-99m methylene diphosphonate ( 99m Tc-MDP) bone scan. [3] CT usually reveals an isodense mass which can have an indistinct or infiltrating margin with some degree of enhancement. [8] Ultrasonographic features include a hypoechoic lesion, which may be heterogeneous due to necrosis, hemorrhage, or calcification. Similar heterogeneity is seen on MRI with the lesions being T2 isointense to hyperintense, T1 isointense to muscle, with heterogeneous contrast enhancement. Serpentine vessels with flow voids are often seen traversing the lesion, which may be surrounded by a pseudocapsule. The lesions are typically hypermetabolic on 18 F FDG-PET/CT although non-FDG-avid lesions have been described. [3, 8] Bone scintigraphy usually demonstrates increased uptake on blood flow and blood pool images, reflecting the hypervascular nature of these lesions, without significant increased uptake on delayed images. [3, 9] Both our cases demonstrate a heterogeneous appearance on ultrasound and MRI, more conspicuous in the first case where a larger mass with extensive calcifications and area of necrosis was present. Minimal necrosis and no definite calcifications characterized the second case, possibly due to the smaller size of the mass. Neither of these lesions demonstrated significant Doppler color flow although a few serpentine flow voids were noted on MR in the second case. Both lesions showed restricted diffusion and heterogeneous contrast-enhancement on MRI. Both primary and metastatic lesions were found to be FDG-avid. The second case did not show definite radiotracer uptake within the mass on blood pool or delayed images on 99m Tc-MDP whole-body scintigraphy study. This examination was not performed for the first patient.
The outcome for Ewing sarcoma is primarily dependent on the presence of distant metastases. In the absence of detectable metastases, 70% of children and adolescents are cured with a combination of intensive, multiagent chemotherapy with surgery and/or radiotherapy. In contrast, <30% of children and adolescents with overt metastases can be cured with current therapy. [10] Although the imaging features of extraskeletal Ewing sarcoma are not specific, they suggest an aggressive, rapidly proliferating mass, which should prompt clinicians to obtain early biopsy confirming pathologic diagnosis. The current consensus for treatment of these lesions includes chemotherapy and delayed surgical resection when feasible, supplemented with radiotherapy if indicated. [5] Initial misdiagnosis can lead to incomplete treatment with recurrent disease. The only case reported treated with partial resection and radiotherapy, misdiagnosed initially as an undifferentiated carcinoma, presented with a cranial metastasis 1 year later. [11] Since imaging is not definitive, a well-structured differential diagnosis for a pediatric or adolescent patient with an aggressive pelvic (extraovarian) lesion should include rhabdomyosarcoma, extraskeletal Ewing sarcoma, synovial sarcoma, malignant melanoma, and less frequently carcinoma. [5, 12, 13] While biopsy is a key in confirming the diagnosis, imaging remains critical in defining the extent of disease, in evaluating response to treatment, and in the detection of recurrent/ metastatic disease.
18 F FDG-PET can play an important role in guiding the biopsy of these heterogeneous, often partially necrotic, vascular tumors.
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